Brief: Senores Pharmaceuticals To Acquire Apnar Pharma
15/12/2025 15:24
Dec 15 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: ENTERS INTO SHARE PURCHASE AGREEMENT TO ACQUIRE APNAR PHARMA TOTAL ENTERPRISE VALUE AT 910 MILLION RUPEES Source text: ID:nBSE7k24lv Further company coverage: SENO.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees